21 research outputs found
Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma as a Bridge to Liver Transplantation: A Retrospective Study
Background. Transcatheter arterial lipiodol chemoembolization (TACE) can be used in cirrhotic patients with hepatocellular carcinoma to avoid tumor progression before transplantation. Objective. To evaluate the efficacy and safety of TACE used as a bridge to liver transplantation. Methods. TACE was performed in 30 cirrhotic patients with hepatocellular carcinoma. Milan criteria were used to select patients for transplant. Patients had a good or moderately impaired liver function, no arterioportal fistulae, and a good portal perfusion. Results. 48 TACE were performed in 30 patients. Before transplantation, 4 patients were dropped off the list due to tumor extension or liver failure. Complete necrosis of the tumor was observed in 11 patients and partial necrosis in 15 patients. After transplantation, 6 patients died and tumor recurrence was observed in 5 patients with a tumor beyond Milan criteria or no response to TACE. Conclusion. TACE is useful as a bridge to liver transplantation in a selected group of cirrhotic patients with hepatocellular carcinoma. A combined therapeutic approach before surgery might improve the prognosis in these patients
La valeur prédictive et pronostique d'une faible expression des récepteurs d'oestrogÚnes en cancer du sein
Lâobjectif de ce projet fut dâĂ©valuer le bĂ©nĂ©fice associĂ© Ă la thĂ©rapie antihormonale (TA) pour les cancers du sein avec des rĂ©cepteurs dâestrogĂšnes (ER) faiblement positifs (< 10 fmol/mg de cytosol). Nous avons identifiĂ© 2221 patientes avec cancer du sein dont ER ont Ă©tĂ© Ă©valuĂ©s par mĂ©thode biochimique (Ligand-Based Assay ou LBA) de 1976 Ă 1995 et suivies jusquâen 2008. Des modĂšles Ă risques proportionnels de Cox ont Ă©tĂ© utilisĂ©s pour Ă©valuer lâimpact des diffĂ©rents niveaux de ER sur la survie au cancer du sein chez les patientes ayant reçu ou non une TA. Parmi les 2221 patientes incluses dans lâĂ©tude, 661 (29,8%) ont reçu une TA. Chez celles avec TA, une diminution significative de la mortalitĂ© spĂ©cifique au cancer du sein nâa Ă©tĂ© dĂ©montrĂ©e que pour les niveaux de ER â„10 fmol/mg de cytosol. Ainsi, ceci ne supporte pas une TA pour les cancers du sein faiblement positif pour ER testĂ©s en LBA.The objective of this project was to evaluate the effect of antihormonal therapy (AT) on patients with weakly positive ER breast cancers (BC) (< 10 fmol/mg of cytosol). We identified 2221 BC patients with ER tested by ligand-based assay (LBA) from 1976 to 1995, treated and followed until 2008. Cox proportional hazards models were used to assess the effect of ER levels on BC survival in patients who received AT. Of 2221 patients studied, 661 (29.8%) received AT. Of those who received AT, there was a significant risk reduction in breast cancer-specific mortality only for patients with ER levels â„10 fmol/mg of cytosol. Therefore our results do not support treating with AT weakly positive ER BC patients identified by LBA
Quality of Life Following the Surgical Management of Gastric Cancer Using Patient-Reported Outcomes: A Systematic Review
Introduction: Surgical management of gastric adenocarcinoma can have a drastic impact on a patientâs quality of life (QoL). There is high variability among surgeonsâ preferences for the type of resection and reconstructive method. Peri-operative and cancer-specific outcomes remain equivalent between the different approaches. Therefore, postoperative quality of life can be viewed as a deciding factor for the surgical approach. The goal of this study was to interrogate patient QoL using patient-reported outcomes (PROs) following gastrectomy for gastric cancer. Methods: This systematic review was registered at Prospero and followed PRISMA guidelines. Medline, Embase, and Scopus were used to perform a literature search on 18 January 2020. A set of selection criteria and the data extraction sheet were predefined. Covidence (Melbourne, Australia) software was used; two reviewers (P.C.V. and E.J.) independently reviewed the articles, and a third resolved conflicts (A.B.F.). Results: The search yielded 1446 studies; 308 articles underwent full-text review. Ultimately, 28 studies were included for qualitative analysis, including 4630 patients. Significant heterogeneity existed between the studies. Geography was predominately East Asian (22/28 articles). While all aspects of quality of life were found to be affected by a gastrectomy, most functional or symptom-specific measures reached baseline by 6â12 months. The most significant ongoing symptoms were reflux, diarrhoea, and nausea/vomiting. Discussion: Generally, patients who undergo a gastrectomy return to baseline QoL by one year, regardless of the type of surgery or reconstruction. A subtotal distal gastrectomy is preferred when proper oncologic margins can be obtained. Additionally, no one form of reconstruction following gastrectomy is statistically preferred over another. However, for subtotal distal gastrectomy, there was a trend toward Roux-en-Y reconstruction as superior to abating reflux
Contralateral mastectomy in young women with breast cancer: A population-based analysis of predictive factors and clinical impact.
Generalizability of common cancer clinical trial eligibility criteria in the real world.
Impact of pre-existing cardiovascular disease (CVD) on patterns of care and outcomes in breast cancer (BC).
Neoadjuvant Radiotherapy Followed by Surgery Compared with Surgery Alone in the Treatment of Retroperitoneal SarcomA: A Population-Based Comparison
Introduction: Retroperitoneal sarcoma (rps) encompasses a heterogeneous group of malignancies with a high recurrence rate after resection. Neoadjuvant radiotherapy (nrt) is often used in the hope of sterilizing margins and decreasing local recurrence after excision. We set out to compare local recurrence-free survival (lrfs) and overall survival (os) in patients treated with or without nrt before resection. Methods: Patients diagnosed with rps from February 1990 to October 2014 were identified in the Alberta Cancer Registry. Patients with complete gross resection of rps and no distant disease were included. Patient, tumour, treatment, and outcomes data were abstracted in a primary chart review. Baseline characteristics were compared using the Wilcoxon nonparametric test for continuous data and the Fisher exact test for dichotomous and categorical data. Survival was analyzed using KaplanâMeier curves with log-rank test. Cox regression was performed to control for age, sex, tumour size, tumour grade, date of diagnosis, multivisceral resection, and intraoperative rupture. Results: Resection alone was performed in 62 patients, and resection after nrt, in 40. Use of nrt was associated with multivisceral resection and negative microscopic margins. On univariate analysis, nrt was associated with superior median lrfs (89.3 months vs. 28.4 months, p = 0.04) and os (119.4 months vs. 75.9 months, p = 0.04). On multivariate analysis, nrt, younger age, and lower tumour grade predicted improved lrfs and os; sex, tumour size, date of diagnosis, multivisceral resection, and tumour rupture did not. Conclusions: In this population-based study, nrt was associated with superior lrfs and os on both univariate and multivariate analysis. When feasible, nrt should be considered until a randomized controlled trial is completed
Development and validation of case-finding algorithms for recurrence of breast cancer using routinely collected administrative data
Abstract Background Recurrence is not explicitly documented in cancer registry data that are widely used for research. Patterns of events after initial treatment such as oncology visits, re-operation, and receipt of subsequent chemotherapy or radiation may indicate recurrence. This study aimed to develop and validate algorithms for identifying breast cancer recurrence using routinely collected administrative data. Methods The study cohort included all young (†40âyears) breast cancer patients (2007â2010), and all patients receiving neoadjuvant chemotherapy (2012â2014) in Alberta, Canada. Health events (including mastectomy, chemotherapy, radiation, biopsy and specialist visits) were obtained from provincial administrative data. The algorithms were developed using classification and regression tree (CART) models and validated against primary chart review. Results Among 598 patients, 121 (20.2%) had recurrence after a median follow-up of 4âyears. The high sensitivity algorithm achieved 94.2% (95% CI: 90.1â98.4%) sensitivity, 93.7% (91.5â95.9%) specificity, 79.2% (72.5â85.8%) positive predictive value (PPV), and 98.5% (97.3â99.6%) negative predictive value (NPV). The high PPV algorithm had 75.2% (67.5â82.9%) sensitivity, 98.3% (97.2â99.5%) specificity, 91.9% (86.6â97.3%) PPV, and 94% (91.9â96.1%) NPV. Combining high PPV and high sensitivity algorithms with additional (7.5%) chart review to resolve discordant cases resulted in 94.2% (90.1â98.4%) sensitivity, 98.3% (97.2â99.5%) specificity, 93.4% (89.1â97.8%) PPV, and 98.5% (97.4â99.6%) NPV. Conclusion The proposed algorithms based on routinely collected administrative data achieved favorably high validity for identifying breast cancer recurrences in a universal healthcare system in Canada
Extent of Groin Dissection in Melanoma: A Mixed-Methods, Population-Based Study of Practice Patterns and Outcomes
Melanoma metastases to the groin are frequently managed by therapeutic lymph node dissection. Evidence is lacking regarding the extent of dissection required. Thus, we sought to describe practice patterns for the use of inguinal vs. ilioinguinal dissection, as well as the perioperative/oncologic outcomes of each procedure. A mixed-methods approach was employed to evaluate surgical practice patterns. A retrospective review of three multi-site databases was carried out, together with semi-structured interviews of melanoma surgeons. A total of 347 patients who underwent dissection were reviewed. The main indications stated for adding a “deep” ilioinguinal dissection were palpable or radiologically positive disease. There was no significant difference in complications, length of stay or lymphedema between patients having inguinal vs. ilioinguinal dissection, irrespective of method of diagnosis. There was also no significant difference in recurrence, cancer-specific survival or overall survival between groups. In conclusion, ilioinguinal dissection is a safe and well-tolerated procedure, with no significant added morbidity relative to an inguinal dissection. The indications for ilioinguinal dissection currently in use produce an appropriate deep node positivity rate and ilioinguinal dissection should continue to be used selectively. Randomized data are needed to clarify the impact of ilioinguinal dissection on regional control and survival